"Chemokine CCL3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CC chemokine with specificity for CCR1 RECEPTORS and CCR5 RECEPTORS. It is a chemoattractant for NK CELLS; MONOCYTES; and a variety of other immune cells. This chemokine is encoded by multiple genes.
| Descriptor ID |
D054405
|
| MeSH Number(s) |
D12.644.276.374.200.110.150 D12.644.276.374.200.600.150 D12.776.467.374.200.110.150 D12.776.467.374.200.600.150 D23.125.300.110.150 D23.125.300.600.500 D23.469.200.110.150 D23.469.200.600.150 D23.529.374.200.110.150 D23.529.374.200.600.150
|
| Concept/Terms |
Chemokine CCL3- Chemokine CCL3
- CCL3, Chemokine
- Chemokine (C-C Motif) Ligand 3
- LD78alpha Chemokine
- Chemokine, LD78alpha
- MIP-1alpha
- Small Inducible Cytokine A3
- CCL3 Chemokine
- Chemokine, CCL3
- Macrophage Inflammatory Protein 1-alpha
- Macrophage Inflammatory Protein 1 alpha
Chemokine CCL3L3- Chemokine CCL3L3
- CCL3L3, Chemokine
- CCL3L3 Chemokine
- Chemokine, CCL3L3
Chemokine CCL3L2- Chemokine CCL3L2
- CCL3L2, Chemokine
- Chemokine (C-C Motif) Ligand 3-Like 2
- CCL3L2 Chemokine
- Chemokine, CCL3L2
Chemokine CCL3L1- Chemokine CCL3L1
- CCL3L1, Chemokine
- Chemokine (C-C Motif) Ligand 3-Like 1
- LD78beta Chemokine
- Chemokine, LD78beta
- CCL3L1 Chemokine
- Chemokine, CCL3L1
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CCL3".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CCL3".
This graph shows the total number of publications written about "Chemokine CCL3" by people in this website by year, and whether "Chemokine CCL3" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CCL3" by people in Profiles.
-
Utility of peripheral protein biomarkers for the prediction of incident interstitial features: a multicentre retrospective cohort study. BMJ Open Respir Res. 2024 Mar 14; 11(1).
-
Improved Risk Stratification in Pediatric Septic Shock Using Both Protein and mRNA Biomarkers. PERSEVERE-XP. Am J Respir Crit Care Med. 2017 08 15; 196(4):494-501.
-
Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype. Crit Care Med. 2016 Nov; 44(11):2010-2017.
-
The bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach. Br J Haematol. 2014 Jul; 166(2):177-88.
-
Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model. PLoS One. 2014; 9(1):e86242.
-
Complement dependency of cardiomyocyte release of mediators during sepsis. FASEB J. 2011 Jul; 25(7):2500-8.
-
CCL3 (MIP-1a) plasma levels and the risk for disease progression in chronic lymphocytic leukemia. Blood. 2011 Feb 03; 117(5):1662-9.
-
Interferon-? attenuates lung inflammation following experimental subarachnoid hemorrhage. Crit Care. 2010; 14(4):R157.
-
CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells. Am J Pathol. 2010 May; 176(5):2177-87.
-
GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain. J Neurosci. 2010 Feb 10; 30(6):2138-49.